FDA Inspection 1192355 — Cardiocommand Inc.

Cardiocommand Inc. — FEI 1927197

The FDA completed an inspection of Cardiocommand Inc. on December 9, 2022 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 9, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Tampa, FL (United States)

Citations

IDCFRDescription
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures